Danilov AV, Flinn IW, Davids MS, Gregory B, Bentur O, Sidransky D, Brown JR. The phase III DUO trial of PI3K inhibitor duvelisib <i>versus</i> ofatumumab in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final analysis including overall survival. haematol [Internet]. 2020Sep.10 [cited 2024Sep.29];. Available from: https://haematologica.org/article/view/haematol.2024.285043